Molecular Partners AG
MOLN4.380USD
-0.010-0.23%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
163.81MMarket Cap
LossP/E TTM
Molecular Partners AG Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
5.63M
-29.38%
EPS(YoY)
-1.75
22.12%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its total revenue reached 5.63M, with a year-on-year change of -29.38%.
What is the Earnings Per Share (EPS) of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its Earnings Per Share (EPS) was -1.750, with a year-on-year change of 22.12%.
What is the net income of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its net income was -61.18M, with a year-on-year change of 12.80%.
What is the net margin of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its net profit margin was -1087.38%, with a year-on-year change of -23.47%.
What is the gross margin of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its gross margin was 99.80%, with a year-on-year change of -0.06%.
What is the debt-to-asset ratio of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its debt-to-asset ratio was 1.54%, with a year-on-year change of -16.27%.
What is the Return on Equity (ROE) of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its Return on Equity (ROE) was -33.98%, with a year-on-year change of -12.83%.
What is the Return on Assets (ROA) of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its Return on Assets (ROA) was -30.29%, with a year-on-year change of -12.53%.
What is the operating profit of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its operating profit was -69.30M, with a year-on-year change of -0.19%.
What are the current assets of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its current assets were 174.64M, with a year-on-year change of -19.83%.
What are the total assets of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its total assets of Molecular Partners AG were 179.45M, with a year-on-year change of -20.07%.
What are the total liabilities of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its total liabilities of Molecular Partners AG were 19.12M, with a year-on-year change of -22.94%.
What is the total equity of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its total equity of Molecular Partners AG was 160.33M, with a year-on-year change of -19.71%.
What is the net operating income of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its net operating income of Molecular Partners AG was -61.18M, with a year-on-year change of 12.80%.
What is the net investment of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its net investment of Molecular Partners AG was 41.03M, with a year-on-year change of -11.17%.
What is the net financing of Molecular Partners AG?
According to Molecular Partners AG's FY2024 earnings report, its net financing of Molecular Partners AG was 16.34M, with a year-on-year change of 1336.90%.
